CIK 0001367083
- Non-accelerated filer
- Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680423298
- Phone
- +1 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,781 shares (grant or award)
- 4 Grant or award Director acquired 1,538 shares (grant or award)
- 4 Grant or award Director acquired 1,052 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 2,400 shares at an average $4.06 ($9,756)
- 4 Open-market buy Chief Financial Officer bought 2,400 shares at an average $3.97 ($9,516)
- 4 Open-market buy Chief Executive Officer bought 2,473 shares at $3.99 ($9,867)
- 4 Grant or award Director acquired 1,424 shares (grant or award)
- 4 Grant or award Director acquired 1,157 shares (grant or award)
- 4 Grant or award Director acquired 1,691 shares (grant or award)
- 4 Grant or award Director acquired 1,958 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 17,211 shares (grant or award)
- 4 Grant or award Director acquired 17,211 shares (grant or award)
- 4 Grant or award Director acquired 17,211 shares (grant or award)
Page 4 of 16 · 317 filings